Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
*End-of-treatment data from two Phase 2a combination clinical trials with imdusiran to be presented at the EASL Congress in June..
RNA interference
News and Video Search Results
News coverage
-
Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)
GlobeNewswire
-
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
PR Newswire Asia
-
Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars
Business Wire
-
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease
Business Wire
0 shares
1 views
You might like
RNA interference media coverage
mRNA in the Food Supply?
Food crops are capable of growing mRNS fragments that can interfere with the DNA of a targeted organ, species, entire race - called..
Rumble